* Mechanism of Coordinated Access to orphan medicinal products (MoCA): is a platform where companies’ issues around reimbursement or financing schemes can be discussed with a variety of jurisdictions and societal perspectives. It provides a mechanism for European countries to collaborate on coordinated access to orphan medicines in a voluntary, dialogue-based approach, intended to create a fluid set of interactions between key stakeholders, across all aspects of a product.
Visit websiteMechanism of Coordinated Access to orphan medicinal products (MoCA)
Provided by EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION
